This week I want to look at where we are with psychedelics, the mind-altering substances that have somehow made the leap from counterculture to major focus of clinical research. Compounds like psilocybin—which is found in magic mushrooms—are being explored for all sorts of health applications, including treatments for depression, PTSD, addiction, and even obesity. Over…
Art investing blends passion with portfolio strategy, offering a long-term, wealth-building asset if you take the time to research the market and buy what you genuinely love.
On this week’s Equity, we sat down with Dennis Green-Leiber, the founder of the AI company Propane, to talk about the booming success of the Nordic ecosystem.